Skin hypoxia - A promoting environmental factor in melanomagenesis

被引:25
作者
Bedogni, Barbara [1 ]
Powell, Marianne Broome [1 ]
机构
[1] Stanford Univ, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA
关键词
skin hypoxia; HIF1; alpha; melanocyte survival/proliferation; Akt; melanomagenesis;
D O I
10.4161/cc.5.12.2810
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Melanomagenesis is a complex phenomenon in which environmental, genetic and host factors play a role. Sun burns in early childhood are a known risk factor in melanoma development. Alteration of prosurvival genes such as Ras and Akt and loss of function of the p16(INK4a)-CDK4/6-pRb and p14(ARF)-HDM2-p53 pathways are strongly associated with human melanoma. We have demonstrated that normally occurring skin hypoxia represents a previously unappreciated host promoting factor in melanomagenesis. Melanocytes that express oncogenes such as Akt, and are therefore genetically unstable, show a transform phenotype only in a mild hypoxic environment that resembles the hypoxic status of the skin. Hypoxia, therefore, is not just a prerogative of advanced neoplasia; physiologic tissue hypoxia, through the activity of HIF1 alpha, can function as a promoting factor in tumorigenesis.
引用
收藏
页码:1258 / 1261
页数:4
相关论文
共 26 条
[1]   Atmospheric oxygen accelerates the induction of a post-mitotic phenotype in human dermal fibroblasts: the key protective role of glutathione [J].
Alaluf, S ;
Muir-Howie, H ;
Hu, HL ;
Evans, A ;
Green, MR .
DIFFERENTIATION, 2000, 66 (2-3) :147-155
[2]  
Balin AK, 2002, IN VITRO CELL DEV-AN, V38, P305
[3]   The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation [J].
Bedogni, B ;
Welford, SM ;
Cassarino, DS ;
Nickoloff, BJ ;
Giaccia, AJ ;
Powell, MB .
CANCER CELL, 2005, 8 (06) :443-454
[4]   Fate of melanocytes during development of the hair follicle pigmentary unit [J].
Botchkareva, NV ;
Botchkarev, VA ;
Gilchrest, BA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2003, 8 (01) :76-79
[5]   Use of human tissue to assess the oncogenic activity of melanoma-associated mutations [J].
Chudnovsky, Y ;
Adams, AE ;
Robbins, PB ;
Lin, Q ;
Khavari, PA .
NATURE GENETICS, 2005, 37 (07) :745-749
[6]   Melanoma genetics and the development of rational therapeutics [J].
Chudnovsky, Y ;
Khavari, PA ;
Adams, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :813-824
[7]  
CORDONCARDO C, 1995, AM J PATHOL, V147, P545
[8]   Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases [J].
Dai, DL ;
Martinka, M ;
Li, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1473-1482
[9]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[10]   Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma [J].
Demunter, A ;
Stas, M ;
Degreef, H ;
De Wolf-Peeters, C ;
van den Oord, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1483-1489